Usher Syndrome Type 3 therapy (Prime Medicine)

N/A

Report date: 2025/09/01 16:35:36

Base Information

Drug NameUsher Syndrome Type 3 therapy (Prime Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsUsher Syndromes, 3
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrime Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrime Medicine Inc
Inactive CompaniesN/A
Active IndicationsUsher Syndromes, 3
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A